- Home
- TR vs CNTA Comparison
TR vs CNTA Comparison
Compare TR & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- CNTA
- Stock Information
- Founded
- TR 1896
- CNTA 2020
- Country
- TR United States
- CNTA United Kingdom
- Employees
- TR N/A
- CNTA N/A
- Industry
- TR Specialty Foods
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- CNTA Health Care
- Exchange
- TR Nasdaq
- CNTA Nasdaq
- Market Cap
- TR 2.3B
- CNTA 2.3B
- IPO Year
- TR N/A
- CNTA 2021
- Fundamental
- Price
- TR $32.39
- CNTA $16.95
- Analyst Decision
- TR
- CNTA Strong Buy
- Analyst Count
- TR 0
- CNTA 7
- Target Price
- TR N/A
- CNTA $23.71
- AVG Volume (30 Days)
- TR 103.4K
- CNTA 607.2K
- Earning Date
- TR 10-24-2024
- CNTA 11-12-2024
- Dividend Yield
- TR 1.10%
- CNTA N/A
- EPS Growth
- TR 7.80
- CNTA N/A
- EPS
- TR 1.31
- CNTA N/A
- Revenue
- TR $727,121,000.00
- CNTA $6,853,000.00
- Revenue This Year
- TR N/A
- CNTA N/A
- Revenue Next Year
- TR N/A
- CNTA N/A
- P/E Ratio
- TR $24.71
- CNTA N/A
- Revenue Growth
- TR N/A
- CNTA N/A
- 52 Week Low
- TR $27.58
- CNTA $6.65
- 52 Week High
- TR $34.80
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- TR 52.84
- CNTA 49.17
- Support Level
- TR $31.43
- CNTA $16.46
- Resistance Level
- TR $32.27
- CNTA $18.00
- Average True Range (ATR)
- TR 0.66
- CNTA 1.19
- MACD
- TR -0.03
- CNTA -0.06
- Stochastic Oscillator
- TR 57.07
- CNTA 34.63
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.